Citations 1
Limitations and Confusing Aspects of Diagnostic Testing for Neurologic Lyme Disease in the United States
Theel, Elitza S. , Aguero‐Rosenfeld, Maria E. , Pritt, Bobbi S. , Adem, Patricia , Wormser, Gary P. , Pritt, Bobbi, Pritt, Bobbi S
Journal of Clinical Microbiology | September 27, 2018 | Volume: 57 | Issue: 1 | Pages: No page available
In the United States, laboratories frequently offer multiple different assays for testing of cerebrospinal fluid (CSF) samples to provide laboratory support for the diagnosis of central nervous system Lyme disease (CNSLD). Often included among these diagnostic tests are the same enzyme immunoassays and immunoblots that are routinely used to detect the presence of antibodies to Borrelia burgdorferi in serum.